financetom
Business
financetom
/
Business
/
--Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment
Apr 26, 2024 4:41 AM

07:26 AM EDT, 04/26/2024 (MT Newswires) --

Price: 25.50, Change: +0.24, Percent Change: +0.95

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Volkswagen explores stock sale in truckmaker Traton, Bloomberg reports
Volkswagen explores stock sale in truckmaker Traton, Bloomberg reports
May 13, 2024
(Reuters) - Volkswagen is exploring the sale of as much as1 billion euros ($1.08 billion) worth of stock in its heavy truckmaking arm Traton SE ( TRATF ), Bloomberg News reported on Monday, citing people familiar with the matter. The German automaker is talking to potential advisers about the stake sale to institutional investors via an accelerated bookbuilding deal as...
Meta exploring AI-assisted earbuds with cameras, The Information reports
Meta exploring AI-assisted earbuds with cameras, The Information reports
May 13, 2024
(Reuters) - Meta Platforms ( META ) is exploring making earphones powered by artificial intelligence with cameras, The Information reported on Monday citing employees familiar with the matter. A slew of companies, from startups to conglomerates including Meta, are looking to develop AI-based wearable devices to capture growing interest in the sector. The Facebook-parent expects the device, being explored under...
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
May 13, 2024
Monday, Takeda Pharmaceutical Company Limited ( TAK ) and AC Immune SA ( ACIU ) announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta (Abeta), including ACI-24.060 for Alzheimer’s disease. ACI-24.060 is an anti-Abeta active immunotherapy candidate designed to induce an antibody response against the toxic forms of Abeta believed to drive plaque formation and Alzheimer’s...
Dutch Bros Insider Sold Shares Worth $4,153,755, According to a Recent SEC Filing
Dutch Bros Insider Sold Shares Worth $4,153,755, According to a Recent SEC Filing
May 13, 2024
01:43 PM EDT, 05/13/2024 (MT Newswires) -- Travis Boersma, 10% Owner, Director, Executive Chairman of Board, on May 10, 2024, sold 115,278 shares in Dutch Bros ( BROS ) for $4,153,755. Following the Form 4 filing with the SEC, Boersma has control over a total of 1,308,967 shares of the company, with 1,308,967 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1866581/000186658124000138/xslF345X03/wk-form4_1715621833.xml Price: 35.21,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved